or Try an Advanced Search...

    Gilead Sciences Stocks List

    Symbol Grade Name % Change
    NRIX B Nurix Therapeutics, Inc. -5.89
    HOOK C HOOKIPA Pharma Inc. -4.17
    GILD F Gilead Sciences, Inc. 0.91
    HEPA F Hepion Pharmaceuticals, Inc. -4.82
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Major
    Related Stock Lists: Biopharmaceutical Biotechnology Cancer Hepatitis B Hepatotoxins Immunodeficiency Life Sciences Liver Disease Medicine Tenofovir Disoproxil Angina Antibiotics Bruton's Tyrosine Kinase Cardiovascular Disease Chronic Liver Disease Chronic Liver Diseases Coronavirus Cyclophilin Cystic Fibrosis Cytomegalovirus Retinitis

    Related ETFs - A few ETFs which own one or more of the above listed Gilead Sciences stocks.

    Symbol Grade Name Weight
    IBB D iShares Nasdaq Biotechnology Index Fund 8.23
    IBBQ D Invesco Nasdaq Biotechnology ETF 8.21
    BBH D Market Vectors Biotech ETF 7.99
    BIS A ProShares UltraShort Nasdaq Biotechnology 7.41
    BIB D ProShares Ultra Nasdaq Biotechnology 6.07
    View all Gilead Sciences ETFs...
    Compare ETFs
    Compare IBB to BIS Compare IBB to IBBQ Compare IBBQ to BIS

        Gilead Sciences Stocks Recent News

        Date Stock Title
        Apr 19 HEPA Hepion ends Phase 2 study for NASH drug due to cash restraints
        Apr 19 HEPA Hepion Pharmaceuticals Initiates Wind-Down Activities in Phase 2b ‘ASCEND-NASH’ Trial
        Apr 19 GILD FDA requires labeling changes to CAR-T cell therapies to reflect cancer risk
        Apr 18 GILD US FDA mandates label updates on CAR-T cancer therapies
        Apr 18 GILD Gilead Sciences (GILD) Sees a More Significant Dip Than Broader Market: Some Facts to Know
        Apr 18 GILD Gilead Sciences Publishes 2023 ESG Impact Report
        Apr 18 GILD Analysts Estimate Gilead Sciences (GILD) to Report a Decline in Earnings: What to Look Out for
        Apr 17 GILD GILEAD SCIENCES JOIN FORCES WITH WORLD HEPATITIS ALLIANCE AND EXPERTS TO AWARD US$4 MILLION ALL4LIVER GRANT FOR VIRAL HEPATITIS ELIMINATION BY 2030, INCLUDING TWO INNOVATIVE INITIATIVES IN ASIA
        Apr 16 NRIX Nurix Therapeutics Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
        Apr 16 HOOK HOOKIPA Pharma Announces Grant of Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
        Apr 16 GILD Xilio's (XLO) Shares Surge 79.8% in a Month: Here's Why
        Apr 16 GILD Gilead Sciences, Inc. (GILD) is Attracting Investor Attention: Here is What You Should Know
        Apr 15 GILD Should You Buy the 3 Highest-Paying Dividend Stocks in the Nasdaq?
        Apr 15 NRIX Roche's (RHHBY) Combination Therapy Meets Goal in Lymphoma Study
        Apr 15 NRIX Nurix Therapeutics Advances Promising Protein Degraders For B-Cell Malignancies
        Apr 15 GILD GILEAD SCIENCES JOIN FORCES WITH WORLD HEPATITIS ALLIANCE AND EXPERTS TO AWARD US$4 MILLION ALL4LIVER GRANT FOR VIRAL HEPATITIS ELIMINATION BY 2030, INCLUDING TWO COMMUNITY-LED INITIATIVES IN ASIA
        Apr 15 GILD GILEAD SCIENCES JOIN FORCES WITH WORLD HEPATITIS ALLIANCE AND EXPERTS TO AWARD US$4 MILLION ALL4LIVER GRANT FOR VIRAL HEPATITIS ELIMINATION BY 2030, INCLUDING TWO COMMUNITY LED INITIATIVES IN HONG KONG
        Related Industries: Biotechnology Drug Manufacturers - Major
        Related Stock Lists: Biopharmaceutical Biotechnology Cancer Hepatitis B Hepatotoxins Immunodeficiency Life Sciences Liver Disease Medicine Tenofovir Disoproxil Angina Antibiotics Bruton's Tyrosine Kinase Cardiovascular Disease Chronic Liver Disease Chronic Liver Diseases Coronavirus Cyclophilin Cystic Fibrosis Cytomegalovirus Retinitis
        Gilead Sciences

        Gilead Sciences, Inc. , is an American biopharmaceutical company headquartered in Foster City, California that researches, develops and commercializes drugs. The company focuses primarily on antiviral drugs used in the treatment of HIV, hepatitis B, hepatitis C, and influenza, including Harvoni and Sovaldi.
        Gilead is a member of the NASDAQ Biotechnology Index and the S&P 500.

        More about Gilead Sciences
        Browse All Tags